These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 19513657
1. Use of fluorescence indicators in receptor ligands. Harikumar KG, Miller LJ. Methods Mol Biol; 2009; 552():279-91. PubMed ID: 19513657 [Abstract] [Full Text] [Related]
2. Use of Fluorescence Indicators in Receptor Ligands. Harikumar KG, Miller LJ. Methods Mol Biol; 2015; 1335():115-30. PubMed ID: 26260598 [Abstract] [Full Text] [Related]
3. Distinct molecular mechanisms for agonist peptide binding to types A and B cholecystokinin receptors demonstrated using fluorescence spectroscopy. Harikumar KG, Clain J, Pinon DI, Dong M, Miller LJ. J Biol Chem; 2005 Jan 14; 280(2):1044-50. PubMed ID: 15520004 [Abstract] [Full Text] [Related]
4. Membrane cholesterol affects stimulus-activity coupling in type 1, but not type 2, CCK receptors: use of cell lines with elevated cholesterol. Harikumar KG, Potter RM, Patil A, Echeveste V, Miller LJ. Lipids; 2013 Mar 14; 48(3):231-44. PubMed ID: 23306829 [Abstract] [Full Text] [Related]
5. Environment and mobility of a series of fluorescent reporters at the amino terminus of structurally related peptide agonists and antagonists bound to the cholecystokinin receptor. Harikumar KG, Pinon DI, Wessels WS, Prendergast FG, Miller LJ. J Biol Chem; 2002 May 24; 277(21):18552-60. PubMed ID: 11893747 [Abstract] [Full Text] [Related]
6. Fluorescence polarization screening for allosteric small molecule ligands of the cholecystokinin receptor. Harikumar KG, Cawston EE, Miller LJ. Assay Drug Dev Technol; 2011 Aug 24; 9(4):394-402. PubMed ID: 21395402 [Abstract] [Full Text] [Related]
7. Use of probes with fluorescence indicator distributed throughout the pharmacophore to examine the peptide agonist-binding environment of the family B G protein-coupled secretin receptor. Harikumar KG, Hosohata K, Pinon DI, Miller LJ. J Biol Chem; 2006 Feb 03; 281(5):2543-50. PubMed ID: 16319066 [Abstract] [Full Text] [Related]
8. Fluorescence characteristics of hydrophobic partial agonist probes of the cholecystokinin receptor. Harikumar KG, Pinon DI, Miller LJ. Biosci Rep; 2006 Apr 03; 26(2):89-100. PubMed ID: 16779661 [Abstract] [Full Text] [Related]
9. Fluorescent indicators distributed throughout the pharmacophore of cholecystokinin provide insights into distinct modes of binding and activation of type A and B cholecystokinin receptors. Harikumar KG, Pinon DI, Miller LJ. J Biol Chem; 2006 Sep 15; 281(37):27072-80. PubMed ID: 16857665 [Abstract] [Full Text] [Related]
10. Use of multidimensional fluorescence resonance energy transfer to establish the orientation of cholecystokinin docked at the type A cholecystokinin receptor. Harikumar KG, Gao F, Pinon DI, Miller LJ. Biochemistry; 2008 Sep 09; 47(36):9574-81. PubMed ID: 18700727 [Abstract] [Full Text] [Related]
19. A stopped-flow fluorescence anisotropy method for measuring hormone binding and dissociation kinetics with cell-surface receptors in living cells. Wilkinson JC, Beechem JM, Staros JV. J Recept Signal Transduct Res; 2002 Sep 09; 22(1-4):357-71. PubMed ID: 12503627 [Abstract] [Full Text] [Related]
20. Live-cell microscopy or fluorescence anisotropy with budded baculoviruses-which way to go with measuring ligand binding to M4 muscarinic receptors? Tahk MJ, Torp J, Ali MAS, Fishman D, Parts L, Grätz L, Müller C, Keller M, Veiksina S, Laasfeld T, Rinken A. Open Biol; 2022 Jun 09; 12(6):220019. PubMed ID: 35674179 [Abstract] [Full Text] [Related] Page: [Next] [New Search]